First-Time Biotech Product Launch Trends & Strategies for Emerging Firms
Emerging pharma first launches held steady in the U.S., were rarer in Europe, and performance vs. forecasts improved versus historical norms. Most novel first launches fall into nano/micro segments, while co-promotes skew toward higher peak sales. For more info : https://www.zs.com/insights/us....-novel-first-launche